When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Holdings is the controlling shareholder of Danish drugmaker Novo Nordisk, which makes the blockbuster GLP-1 injectable ...

With Novo Nordisk’s name already synonymous with treatments for diabetes and obesity, the Danish drugmaker has been making a ...

When you think of a top weight loss drug, chances are that Ozempic is the name that first comes to mind. Although it is ...

The company behind KitKat has launched a protein drink that it claims suppresses appetite in the same way as popular ...

A new class of weight loss drugs developed by Novo Nordisk and Eli Lilly “opens the possibility of an end to the obesity ...

Recent sales of a little-known stock, Madrigal Pharmaceuticals (NASDAQ: MDGL), could bode well for Novo Nordisk A/S (NYSE: ...

Following an appeal by the Danish Medicines Agency, the European Union’s drug regulator will review two new studies that have ...

Danish health authorities asked the European Union to review two studies linking Novo Nordisk's diabetes drug, Ozempic, to a rare eye condition.

Novo Holdings has completed its $16.5 billion takeover of Catalent, the contract drug manufacturer announced on Wednesday, ...

The agency, which oversees Medicare plans for people aged 65 and older or with disabilities, said healthcare spending ...

Nestle is launching protein shots in the United States, which it says help suppress appetite for people looking to shed ...